SCHEMBL14723529

SCHEMBL14723529

N#CN1CCC(NCC(F)(F)F)CC1

nearest known ligand 0.41

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.41
IRAK4 Q9NWZ3 1/20 0.38
CTSK P43235 10/20 0.36
USP30 Q70CQ3 7/20 0.35
CTSB P07858 9/20 0.33
CTSL P07711 6/20 0.33
CTSS P25774 5/20 0.33
CTSC P53634 4/20 0.33
UCHL1 P09936 4/20 0.32
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11145232 0.75
SCHEMBL16015436 0.75 DPP7 (0.44)
SCHEMBL14730193 0.75 JAK2 (0.33)
Hydrochloric Acid SCHEMBL28691974 0.72 TLR7 (0.34)
SCHEMBL12827029 0.71 KDM4E (0.34) IRAK4DPP4
SCHEMBL19020836 0.71 KDM4E (0.39) IRAK4DPP4
Hydrochloric Acid SCHEMBL29424737 0.70 KDM4E (0.39)
SCHEMBL28202703 0.70 ALDH1A1 (0.44) DPP4
SCHEMBL28202704 0.70 TEAD1 (0.31)
SCHEMBL3872945 0.70 HRH3 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed